文献速递胃肠动力与功能性疾病

胃与胃上嗳气、吞气症及反刍综合征的诊断与管理综述

Diagnostic and Management Review of Gastric and Supragastric Belching, Aerophagia, and Rumination Syndrome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-08-21

该叙述性综述通过系统检索近二十年文献,总结胃上嗳气、反刍综合征、过度胃嗳气及吞气症的临床表现、病理生理、诊断与治疗。胃上嗳气和反刍综合征可通过pH-阻抗测试或高分辨率阻抗测压客观确认,心理教育与行为治疗有效;过度胃嗳气以巴氯芬为主要治疗;吞气症少有症状,以行为调整为主。

要点

  • 胃上嗳气与反刍综合征可通过pH-阻抗或高分辨率阻抗测压客观确认。
  • 心理教育与行为治疗对胃上嗳气和反刍综合征有效。
  • 过度胃嗳气以巴氯芬为主要治疗,吞气症以行为调整为主。

核心结论

  • 胃上嗳气、反刍综合征、过度胃嗳气和吞气症具有不同的病理生理和治疗策略,需针对性管理。

研究设计与样本

  • 叙述性综述,通过系统检索近二十年文献综合当前证据。

主要发现

  • 胃上嗳气、反刍综合征、过度胃嗳气和吞气症的病理生理不同,症状和心理社会负担各异。
  • 胃上嗳气和反刍综合征可通过pH-阻抗测试或高分辨率阻抗测压客观确认。
  • 心理教育和行为治疗策略可有效管理胃上嗳气和反刍综合征。
  • 过度胃嗳气以巴氯芬为主要治疗,行为策略在此方面探索不足。
  • 吞气症少有症状,管理包括行为调整。

临床怎么用

  • 临床评估在诊断中起关键作用,必要时使用pH-阻抗或高分辨率阻抗测压确认。
  • 对胃上嗳气和反刍综合征采用心理教育和行为治疗。
  • 过度胃嗳气考虑巴氯芬治疗,吞气症以行为调整为主。
  • 评估继发性病因对全面有效治疗至关重要。

局限性

  • 缺乏正式指南指导的治疗和验证的测量工具来证明干预效果。
  • 需要进一步研究评估多学科行为治疗策略及验证结局测量工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Supragastric belching and rumination syndrome are distressing and potentially debilitating gastrointestinal disorders. Though related, these conditions are distinct from aerophagia and excessive gastric belching. Although diagnostic standards and effective treatment strategies are emerging, formal guideline-directed treatment and validated measurement tools to demonstrate efficacy of interventions are lacking. This narrative review synthesizes current evidence in presentation, pathophysiology, diagnosis, and treatment through a systematic search of the literature over the past 2 decades. Supragastric belching, rumination syndrome, excessive gastric belching, and aerophagia have distinct physiologies and vary in symptomatic and psychosocial burden. Although clinical evaluation plays a key role in diagnosis, supragastric belching and rumination syndrome can be objectively confirmed through pH-impedance testing or high-resolution impedance manometry. Supragastric belching and rumination syndrome can be managed effectively with psychoeducation and behavioral treatment strategies. These strategies are underexplored in excessive gastric belching, for which baclofen remains a primary therapy. Aerophagia is rarely symptomatic, and management is comprised of behavioral modifications. Further studies evaluating multidisciplinary behavioral therapy strategies with validated outcome measurement tools are needed to develop management guidelines and improve the lives of patients with these complex conditions. Evaluation for secondary causes is key to well-rounded, effective treatment.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Liu K, Walsh E, Katzka D, et al. Diagnostic and Management Review of Gastric and Supragastric Belching, Aerophagia, and Rumination Syndrome. Clin Gastroenterol Hepatol. 2025. PMID: 40848911. doi:10.1016/j.cgh.2025.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。